ASCO26: Toni Choueiri, MD, KEYNOTE-654

• July 1, 2026

Evaluating the Prognostic Nutritional Index in Renal Cell Carcinoma Patients: A Comprehensive Systematic Review and Meta-Analysis Update

• by Zhuo Xu, Leihong Xie, Hanchao Zhang, Guanghui Han, Weiquan Guo

• February 14, 2026

Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomes

• by Quynh Chi Le, Mattia Longoni, Andrea Marmiroli, Fabian Falkenbach, Calogero Catanzaro, Michele Nicolazzini, Federico Polverino, Jordan A. Goyal, Fred Saad, Riccardo Schiavina, Luca Fabio Carmignani, Alberto Briganti, Nicola Longo, Markus Graefen, Carlotta Palumbo, Miriam Traumann, Felix K.-H. Chun, Pierre I. Karakiewicz

• November 11, 2025

Dana-Farber’s Dr. Toni Choueiri Elected to the Association of American Physicians

Dana-Farber Cancer Institute’s Dr. Toni Choueiri, Director of the Lank Center for Genitourinary Oncology, was recently elected to one of the nation’s most prestigious medical organizations, The Association of American Physicians (AAP).

• April 20, 2026

• 2 min